Document is current
Any future updates will be listed below
-
Authors
Arunachalam, Prabhu S.
Charles, Tysheena P.
Joag, Vineet http://orcid.org/0000-0002-0723-3347
Bollimpelli, Venkata S.
Scott, Madeleine K. D.
Wimmers, Florian
Burton, Samantha L.
Labranche, Celia C.
Petitdemange, Caroline
Gangadhara, Sailaja http://orcid.org/0000-0001-8603-628X
Styles, Tiffany M.
Quarnstrom, Clare F.
Walter, Korey A.
Ketas, Thomas J.
Legere, Traci
Jagadeesh Reddy, Pradeep Babu
Kasturi, Sudhir Pai
Tsai, Anthony
Yeung, Bertrand Z.
Gupta, Shakti
Tomai, Mark
Vasilakos, John
Shaw, George M.
Kang, Chil-Yong
Moore, John P. http://orcid.org/0000-0002-9902-6096
Subramaniam, Shankar
Khatri, Purvesh
Montefiori, David
Kozlowski, Pamela A.
Derdeyn, Cynthia A. http://orcid.org/0000-0002-1220-513X
Hunter, Eric http://orcid.org/0000-0002-4273-8631
Masopust, David http://orcid.org/0000-0002-9440-3884
Amara, Rama R. http://orcid.org/0000-0002-6309-6797
Pulendran, Bali http://orcid.org/0000-0001-6517-4333
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (UM1AI100663, HIVRAD P01 AI 110657, UM1AI100663, UM1AI100663)
Bill and Melinda Gates Foundation
- License Information
-
More Information
Article History
Received: 4 December 2019
Accepted: 27 March 2020
First Online: 11 May 2020
Competing interests
: M.T. and J.V. are employees of 3M, the manufacturer of 3M-052 used as an adjuvant in this study.
